Results
|
61.
|
Viral dynamics in human immunodeficiency virus type 1 infection. [electronic resource] by
- Wei, X
- Ghosh, S K
- Taylor, M E
- Johnson, V A
- Emini, E A
- Deutsch, P
- Lifson, J D
- Bonhoeffer, S
- Nowak, M A
- Hahn, B H
Producer: 19950203
In:
Nature vol. 373
Availability: No items available.
|
|
62.
|
Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. [electronic resource] by
- Yasutomi, Y
- Koenig, S
- Haun, S S
- Stover, C K
- Jackson, R K
- Conard, P
- Conley, A J
- Emini, E A
- Fuerst, T R
- Letvin, N L
Producer: 19930420
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 150
Availability: No items available.
|
|
63.
|
Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. [electronic resource] by
- Emini, E A
- Schleif, W A
- Nunberg, J H
- Conley, A J
- Eda, Y
- Tokiyoshi, S
- Putney, S D
- Matsushita, S
- Cobb, K E
- Jett, C M
Producer: 19920325
In:
Nature vol. 355
Availability: No items available.
|
|
64.
|
Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein. [electronic resource] by
- Emini, E A
- Larson, V
- Eichberg, J
- Conard, P
- Garsky, V M
- Lee, D R
- Ellis, R W
- Miller, W J
- Anderson, C A
- Gerety, R J
Producer: 19890707
In:
Journal of medical virology vol. 28
Availability: No items available.
|
|
65.
|
|
|
66.
|
A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years. [electronic resource] by
- Schwarz, T F
- Flamaing, J
- Rümke, H C
- Penzes, J
- Juergens, C
- Wenz, A
- Jayawardene, D
- Giardina, P
- Emini, E A
- Gruber, W C
- Schmoele-Thoma, B
Producer: 20120118
In:
Vaccine vol. 29
Availability: No items available.
|
|
67.
|
Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D. [electronic resource] by
- Conley, A J
- Gorny, M K
- Kessler, J A
- Boots, L J
- Ossorio-Castro, M
- Koenig, S
- Lineberger, D W
- Emini, E A
- Williams, C
- Zolla-Pazner, S
Producer: 19941117
In:
Journal of virology vol. 68
Availability: No items available.
|
|
68.
|
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. [electronic resource] by
- Saag, M S
- Emini, E A
- Laskin, O L
- Douglas, J
- Lapidus, W I
- Schleif, W A
- Whitley, R J
- Hildebrand, C
- Byrnes, V W
- Kappes, J C
Producer: 19931014
In:
The New England journal of medicine vol. 329
Availability: No items available.
|
|
69.
|
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications. [electronic resource] by
- LaRosa, G J
- Weinhold, K
- Profy, A T
- Langlois, A J
- Dreesman, G R
- Boswell, R N
- Shadduck, P
- Bolognesi, D P
- Matthews, T J
- Emini, E A
Producer: 19911009
In:
Science (New York, N.Y.) vol. 253
Availability: No items available.
|
|
70.
|
Benzocycloalkyl amines as novel C-termini for HIV protease inhibitors. [electronic resource] by
- Lyle, T A
- Wiscount, C M
- Guare, J P
- Thompson, W J
- Anderson, P S
- Darke, P L
- Zugay, Z A
- Emini, E A
- Schleif, W A
- Qunitero, J C
Producer: 19910417
In:
Journal of medicinal chemistry vol. 34
Availability: No items available.
|
|
71.
|
Antigenic analysis of the Epstein-Barr virus major membrane antigen (gp350/220) expressed in yeast and mammalian cells: implications for the development of a subunit vaccine. [electronic resource] by
- Emini, E A
- Schleif, W A
- Armstrong, M E
- Silberklang, M
- Schultz, L D
- Lehman, D
- Maigetter, R Z
- Qualtiere, L F
- Pearson, G R
- Ellis, R W
Producer: 19881114
In:
Virology vol. 166
Availability: No items available.
|
|
72.
|
X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform. [electronic resource] by
- Chen, Z
- Yan, Y
- Munshi, S
- Li, Y
- Zugay-Murphy, J
- Xu, B
- Witmer, M
- Felock, P
- Wolfe, A
- Sardana, V
- Emini, E A
- Hazuda, D
- Kuo, L C
Producer: 20000323
In:
Journal of molecular biology vol. 296
Availability: No items available.
|
|
73.
|
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. [electronic resource] by
- Byrnes, V W
- Emini, E A
- Schleif, W A
- Condra, J H
- Schneider, C L
- Long, W J
- Wolfgang, J A
- Graham, D J
- Gotlib, L
- Schlabach, A J
Producer: 19941017
In:
Antimicrobial agents and chemotherapy vol. 38
Availability: No items available.
|
|
74.
|
3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitors. [electronic resource] by
- Ghosh, A K
- Thompson, W J
- McKee, S P
- Duong, T T
- Lyle, T A
- Chen, J C
- Darke, P L
- Zugay, J A
- Emini, E A
- Schleif, W A
Producer: 19930219
In:
Journal of medicinal chemistry vol. 36
Availability: No items available.
|
|
75.
|
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted design. [electronic resource] by
- Thompson, W J
- Fitzgerald, P M
- Holloway, M K
- Emini, E A
- Darke, P L
- McKeever, B M
- Schleif, W A
- Quintero, J C
- Zugay, J A
- Tucker, T J
Producer: 19920623
In:
Journal of medicinal chemistry vol. 35
Availability: No items available.
|
|
76.
|
Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzees. [electronic resource] by
- Emini, E A
- Schleif, W A
- Quintero, J C
- Conard, P G
- Eichberg, J W
- Vlasuk, G P
- Lehman, E D
- Polokoff, M A
- Schaeffer, T F
- Schultz, L D
Producer: 19910426
In:
AIDS research and human retroviruses vol. 6
Availability: No items available.
|
|
77.
|
Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates. [electronic resource] by
- Kessler, J A
- McKenna, P M
- Emini, E A
- Chan, C P
- Patel, M D
- Gupta, S K
- Mark, G E
- Barbas, C F
- Burton, D R
- Conley, A J
Producer: 19970709
In:
AIDS research and human retroviruses vol. 13
Availability: No items available.
|
|
78.
|
Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitors. [electronic resource] by
- Ghosh, A K
- Thompson, W J
- Lee, H Y
- McKee, S P
- Munson, P M
- Duong, T T
- Darke, P L
- Zugay, J A
- Emini, E A
- Schleif, W A
Producer: 19930430
In:
Journal of medicinal chemistry vol. 36
Availability: No items available.
|
|
79.
|
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase. [electronic resource] by
- Williams, T M
- Ciccarone, T M
- MacTough, S C
- Rooney, C S
- Balani, S K
- Condra, J H
- Emini, E A
- Goldman, M E
- Greenlee, W J
- Kauffman, L R
Producer: 19930609
In:
Journal of medicinal chemistry vol. 36
Availability: No items available.
|
|
80.
|
L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro. [electronic resource] by
- Goldman, M E
- O'Brien, J A
- Ruffing, T L
- Nunberg, J H
- Schleif, W A
- Quintero, J C
- Siegl, P K
- Hoffman, J M
- Smith, A M
- Emini, E A
Producer: 19920922
In:
Antimicrobial agents and chemotherapy vol. 36
Availability: No items available.
|